PYCR1 and cancer: Alternatively, interconversions of proline and P5C in the cytosol and mitochondria have been proposed as a means of transferring reducing equivalents between these compartments [55], though more detailed functional analyses are required to elucidate how proline metabolism contributes to cancer progression.